CTLA4 and diabetes mellitus: Approximately 97% of all reported cases of ICI-induced diabetes occurred in patients treated with PD-1/PD-L1 inhibitor or a combination of PD-1/PD-L1 inhibitor plus CTLA-4 inhibitor, whereas reports of cases on CTLA-4 inhibitor monotherapy are very rare [3,7].